These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 549256)

  • 41. Use of intravenous amrinone in the short-term management of refractory heart failure in pregnancy.
    Jelsema RD; Bhatia RK; Ganguly S
    Obstet Gynecol; 1991 Nov; 78(5 Pt 2):935-6. PubMed ID: 1923233
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Hemodynamic effect of domestic amrinone in patients with congestive heart failure and pulmonary hypertension].
    Niu XL
    Zhonghua Xin Xue Guan Bing Za Zhi; 1988 Feb; 16(1):22-5. PubMed ID: 3191840
    [No Abstract]   [Full Text] [Related]  

  • 43. [Hemodynamic effects of intravenous perfusion of amrinone in increasing doses in 12 patients with severe heart decompensation].
    Hagemeijer F; t'Hart C; van Mechelen R; Schelling A
    Rev Med Interne; 1987; 8(2):223-9. PubMed ID: 3589216
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical safety of intravenous amrinone--a review.
    Treadway G
    Am J Cardiol; 1985 Jul; 56(3):39B-40B. PubMed ID: 3895878
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intravenous amrinone: an advance or a wrong step?
    Franciosa JA
    Ann Intern Med; 1985 Mar; 102(3):399-400. PubMed ID: 3970477
    [No Abstract]   [Full Text] [Related]  

  • 46. Oral bioavailability and intravenous pharmacokinetics of amrinone in humans.
    Park GB; Kershner RP; Angellotti J; Williams RL; Benet LZ; Edelson J
    J Pharm Sci; 1983 Jul; 72(7):817-9. PubMed ID: 6886991
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intravenous amrinone therapy: nursing implications.
    Fabius DB; Rein A
    Dimens Crit Care Nurs; 1990; 9(6):336-42. PubMed ID: 2226115
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adverse effects of long-term amrinone administration in congestive heart failure.
    Dunkman WB; Wilen MM; Franciosa JA
    Am Heart J; 1983 May; 105(5):861-3. PubMed ID: 6846131
    [No Abstract]   [Full Text] [Related]  

  • 49. A symposium: Amrinone. Introduction.
    Braunwald E
    Am J Cardiol; 1985 Jul; 56(3):1B-2B. PubMed ID: 4025152
    [No Abstract]   [Full Text] [Related]  

  • 50. Amrinone metabolism.
    Kullberg MP; Freeman GB; Biddlecome C; Alousi AA; Edelson J
    Clin Pharmacol Ther; 1981 Mar; 29(3):394-401. PubMed ID: 7471610
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dose proportionality of amrinone.
    Edelson J; Park GB; Angellotti J; Kershner RP; Ryan JJ; McMahon FG
    Clin Pharmacol Ther; 1983 Aug; 34(2):190-4. PubMed ID: 6872413
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intravenous amrinone.
    Goldstein RA; Naccarelli GV
    Ann Intern Med; 1985 Oct; 103(4):643-4. PubMed ID: 4037573
    [No Abstract]   [Full Text] [Related]  

  • 53. Intravenous amrinone therapy at home for the patient with chronic congestive heart failure.
    Moore J
    Focus Crit Care; 1988 Dec; 15(6):32-7. PubMed ID: 3203787
    [No Abstract]   [Full Text] [Related]  

  • 54. [Experimental and clinical pharmacokinetics of amrinone].
    Padrini R; Miglioli PA; Casiglia E; Piovan D; Ferrari M
    Cardiologia; 1982; 27(1):103-6. PubMed ID: 6927443
    [No Abstract]   [Full Text] [Related]  

  • 55. The risks and benefits of intravenous amrinone therapy.
    Haddad A
    Home Healthc Nurse; 1992; 10(5):17-8, 70. PubMed ID: 1526796
    [No Abstract]   [Full Text] [Related]  

  • 56. Growth hormone in end-stage heart failure.
    Wilmshurst P
    Lancet; 1997 Jun; 349(9068):1842-3. PubMed ID: 9269242
    [No Abstract]   [Full Text] [Related]  

  • 57. Hemodynamic effects of intravenous injections affecting the level of blood sugar.
    BOUNOUS G; SHUMACKER HB
    Ann Surg; 1960 Apr; 151(4):453-9. PubMed ID: 13803278
    [No Abstract]   [Full Text] [Related]  

  • 58. Amrinone--promising innovation for treatment of the failing heart.
    Hayward R
    Intensive Care Med; 1983; 9(1):1-3. PubMed ID: 6833622
    [No Abstract]   [Full Text] [Related]  

  • 59. Acute haemodynamic comparison of amrinone and pirbuterol in chronic heart failure. Additional effects of isosorbide dinitrate.
    Bayliss J; Norell M; Canepa-Anson R; Reuben SR; Poole-Wilson PA; Sutton GC
    Br Heart J; 1983 Mar; 49(3):214-21. PubMed ID: 6830658
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.